Cite
The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases.
MLA
Zhang, Lei, et al. “The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases.” Journal of Diabetes Research, June 2018, pp. 1–10. EBSCOhost, https://doi.org/10.1155/2018/9363461.
APA
Zhang, L., Wang, Q., Liu, W., Liu, F., Ji, A., & Li, Y. (2018). The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases. Journal of Diabetes Research, 1–10. https://doi.org/10.1155/2018/9363461
Chicago
Zhang, Lei, Qun Wang, Wen Liu, Fangyan Liu, Ailing Ji, and Yanzhang Li. 2018. “The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases.” Journal of Diabetes Research, June, 1–10. doi:10.1155/2018/9363461.